Effect of norfloxacin on Staphylococcus aureus and Pseudomonas aeruginosa in broth, serum and in combination with human polymorphonuclear leukocytes.
D000900:Anti-Bacterial Agents / Q000633:toxicity*; D006801:Humans; D009268:Nalidixic Acid / Q000031:analogs & derivatives* / Q000097:blood / Q000633:toxicity; D009504:Neutrophils / Q000502:physiology*; D009643:Norfloxacin; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000254:growth & development*; D013211:Staphylococcus aureus / Q000187:drug effects / Q000254:growth & development*
D000900:Anti-Bacterial Agents; D009268:Nalidixic Acid; D009643:Norfloxacin